Trials / Unknown
UnknownNCT03245632
Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 800 (estimated)
- Sponsor
- Sir Run Run Shaw Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Klebsiella pneumoniae is one of the most common pathogens causing nosocomial infection. Recently, the emergency of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) had cause the clinical therapy be very difficult. However, there is not much empirical data as to the prevalence, risk factors, characteristics, and the rationality of the current therapy for the CRKP infection. Thus, the study was aimed to investigate the epidemiology and risk factors, characteristics, and the rationality of the current therapy for the CRKP infection.
Detailed description
All the patients with culture positive of Klebsiella pneumoniae were screened and reported to the the clinical doctors and confirmed by them. And the clinical characteristics of the patiens, such as baseline data, outcomes etc, were recorded. Finially, to find the prevalence, risk factors, characteristics, and the rationality of the current therapy for the CRKP infection
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Carbapenem-Resistant Klebsiella pneumoniae | no intervention, this is an obervational study. |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2019-07-01
- Completion
- 2019-12-01
- First posted
- 2017-08-10
- Last updated
- 2017-08-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03245632. Inclusion in this directory is not an endorsement.